Tg Therapeutics (TGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 2,321 | 2,030 | 1,545 | 793 | 38 |
| Cost of Goods | 211 | 292 | 148 | 139 | N/A |
| Gross Profit | 2,110 | 1,738 | 1,397 | 654 | 38 |
| Operating Expenses | 95,270 | 87,158 | 79,036 | 89,995 | 86,820 |
| Operating Income | -92,948 | -85,128 | -77,492 | -89,202 | -86,782 |
| Interest Expense | 1,079 | 1,038 | 1,623 | 1,898 | 1,290 |
| Other Income | 687 | 529 | 619 | 472 | -146 |
| Pre-tax Income | -93,340 | -85,637 | -78,496 | -90,628 | -88,218 |
| Net Income Continuous | -93,340 | -85,637 | -78,496 | -90,628 | -88,218 |
| Net Income | $-93,340 | $-85,637 | $-78,496 | $-90,628 | $-88,218 |
| EPS Basic Total Ops | -0.70 | -0.65 | -0.59 | -0.69 | -0.74 |
| EPS Basic Continuous Ops | -0.70 | -0.65 | -0.59 | -0.69 | -0.74 |
| EPS Diluted Total Ops | -0.70 | -0.65 | -0.59 | -0.69 | -0.74 |
| EPS Diluted Continuous Ops | -0.70 | -0.65 | -0.59 | -0.69 | -0.74 |
| EBITDA(a) | $-92,334 | $-84,629 | $-76,931 | $-88,785 | $-86,237 |